Standout Papers

Inflammation in obesity, diabetes, and related disorders 2022 2026 2023 20241.0k
  1. Inflammation in obesity, diabetes, and related disorders (2022)
    Theresa V. Rohm, Daniel T. Meier et al. Immunity

Citation Impact

Citing Papers

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Human cell types important for Hepatitis C Virus replication in vivo and in vitro. Old assertions and current evidence
2011
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
2020 Standout
Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association
2013
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Cytokine production by islets in health and diabetes: cellular origin, regulation and function
2010
IL-4 polarized human macrophage exosomes control cardiometabolic inflammation and diabetes in obesity
2022
Inflammatory links between obesity and metabolic disease
2011 Standout
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
2016 StandoutNobel
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
2013
Targeting inflammation in the treatment of type 2 diabetes: time to start
2014
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
2014 Standout
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes
2010
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Connecting Type 1 and Type 2 Diabetes through Innate Immunity
2012
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
2014
Type 2 diabetes as an inflammatory disease
2011 Standout
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Inflammatory Effects of High and Moderate Intensity Exercise—A Systematic Review
2020 Standout
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
2015
Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications
2016
An Integrated View of Immunometabolism
2018
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
An Updated Review on Cancer Risk Associated with Incretin Mimetics and Enhancers
2015
Blockade of interleukin 1 in type 1 diabetes mellitus
2010
The Inflammasomes
2010 Standout
Proteobacteria: microbial signature of dysbiosis in gut microbiota
2015 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
2013
Type 2 diabetes mellitus
2015 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Nutrition, inflammation and cancer
2017
Inflammation in Obesity and Diabetes: Islet Dysfunction and Therapeutic Opportunity
2013
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Role of IL-1β in type 2 diabetes
2010
The emerging role of HDL in glucose metabolism
2012
Inflammasomes in health and disease
2012 StandoutNature
Inflammageing and metaflammation: The yin and yang of type 2 diabetes
2017
Cellular senescence: from physiology to pathology
2014 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
2010 Science
Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls
2013
Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis
2020
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
The Inflammasome in Atherosclerosis and Type 2 Diabetes
2011
Differential Effects of Protein Kinase B/Akt Isoforms on Glucose Homeostasis and Islet Mass
2009
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
2011
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Inflammatory Mechanisms in Obesity
2011 Standout
Regulation of metabolism by the innate immune system
2015
Macrophages and islet inflammation in type 2 diabetes
2013
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
GLP-1 receptor agonists today
2011
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Anti‐inflammatory effects of exercise: role in diabetes and cardiovascular disease
2017

Works of Daniel T. Meier being referenced

Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation
2017
Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents
2010
Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice
2014
Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I
2009
One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice
2013
Low- and High-Density Lipoproteins Modulate Function, Apoptosis, and Proliferation of Primary Human and Murine Pancreatic β-Cells
2009
Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease
2019
Rankless by CCL
2026